111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis

Roberto Mota1,2, Matthew J Campen3, Matthew E Cuellar4

  • 1Radiopharmaceutical Sciences, University of New Mexico (UNM), Albuquerque, NM, USA.

Insights

This study introduces 111In-DANBIRT, a novel imaging probe for detecting inflammation in atherosclerosis. It shows promise for noninvasively diagnosing vulnerable plaques and assessing disease progression.

Area of Science:

  • Cardiovascular Research
  • Molecular Imaging
  • Inflammation Biology

Background:

  • Atherosclerosis poses a significant global health burden, with early diagnosis of vulnerable plaques remaining challenging.
  • Inflammation is a critical driver of atherosclerotic plaque development and associated complications.
  • Current diagnostic methods often fail to detect the transition from early lesions to high-risk plaques.

Purpose of the Study:

  • To evaluate 111In-DANBIRT as an in vivo, noninvasive SPECT/CT imaging probe.
  • To target Lymphocyte Function Associated Antigen-1 (LFA-1), an inflammatory marker in atherosclerotic plaques.
  • To assess the probe's efficacy in detecting inflammation and disease progression.

Main Methods:

  • Assessed selective binding of 111In-DANBIRT in ozone-exposed rats to induce inflammation.
  • Utilized apolipoprotein E-deficient (apoE-/-) mice on high-fat diets to model atherosclerosis.
  • Performed longitudinal SPECT/CT imaging, biodistribution studies, and 3D autoradiography.

Main Results:

  • 111In-DANBIRT showed increased uptake by neutrophils in an acute inflammatory model.
  • SPECT/CT imaging revealed a significant, time-dependent increase in 111In-DANBIRT uptake in atherosclerotic lesions of high-fat diet-fed mice.
  • Histological analysis confirmed increased vascular lesion area correlating with imaging findings.

Conclusions:

  • 111In-DANBIRT demonstrates potential as a molecular imaging probe for assessing inflammation in atheroma.
  • The probe can noninvasively monitor the progression of atherosclerotic plaques.
  • This technology may aid in the early diagnosis of vulnerable atherosclerotic disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
399
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.7K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
532
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K